C. Rousseaux, C. Dubuquoy, S. Bellinvia, F. Viti, J.F. Colombel, P. Chavatte, P. Desreumaux
{"title":"新型口服生物可利用PPAR配体GED-0507-34-Levo治疗炎症性肠病的临床前和毒理学评估","authors":"C. Rousseaux, C. Dubuquoy, S. Bellinvia, F. Viti, J.F. Colombel, P. Chavatte, P. Desreumaux","doi":"10.1016/S1873-9954(10)70059-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100770,"journal":{"name":"Journal of Crohn's and Colitis Supplements","volume":"4 1","pages":"Page 31"},"PeriodicalIF":0.0000,"publicationDate":"2010-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1873-9954(10)70059-8","citationCount":"0","resultStr":"{\"title\":\"S32 Preclinical and toxicological assessments of the novel orally bioavailable PPAR ligand GED-0507-34-Levo for the treatment of inflammatory bowel disease\",\"authors\":\"C. Rousseaux, C. Dubuquoy, S. Bellinvia, F. Viti, J.F. Colombel, P. Chavatte, P. Desreumaux\",\"doi\":\"10.1016/S1873-9954(10)70059-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100770,\"journal\":{\"name\":\"Journal of Crohn's and Colitis Supplements\",\"volume\":\"4 1\",\"pages\":\"Page 31\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1873-9954(10)70059-8\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Crohn's and Colitis Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1873995410700598\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Crohn's and Colitis Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873995410700598","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
S32 Preclinical and toxicological assessments of the novel orally bioavailable PPAR ligand GED-0507-34-Levo for the treatment of inflammatory bowel disease